| |
| | Bio Alberta (Site not responding. Last check: 2007-10-16) |
 | | EDMONTON, ALBERTA -- (CCNMatthews - Oct. 24 2005) - ViRexx Medical Corp. (TSX:VIR), a company focused on immunotherapy treatments for cancer,chronic hepatitis B & C and embolotherapy treatments for tumors today announced that Dr. Lorne Tyrrell has been named the Company's Chief Executive Officer by the Board of Directors effective November 1, 2005. |
 | | Tyrrell, a former dean of the Faculty of Medicine and Dentistry at the University of Alberta who has helped shape policy in education, health care and health research in Canada, is currently Chief Scientific Officer of ViRexx and co-founded the Company with Dr. Noujaim in 2001. |
 | | Tyrrell has received numerous awards during his career including the Order of Canada, the Alberta Order of Excellence, the national Prix Galien award, the Canadian Medical Association's top research prize, the FNG Starr Award and most recently, the Ernest C. Manning Awards Foundation's Principal award given annually to Canada's leading innovator. |
| www.bioalberta.com /news/DetailsPage.cfm?ID=3714 (341 words) |
|